TY - JOUR
T1 - Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse
AU - Cramer, Samuel W.
AU - Popa, Laurentiu S.
AU - Carter, Russell E.
AU - Chen, Gang
AU - Ebner, Timothy J.
N1 - Publisher Copyright:
© 2015 the authors.
PY - 2015/4/8
Y1 - 2015/4/8
N2 - The Ca 2+ channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Ca v2.1 (P/Q-type) voltage-gated Ca 2+ channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering (tg/tg) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg/tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg/tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca 2+ channel function in either wild-type (WT) or tg/tg mice does not induce the high-power state. In contrast, blocking L-type Ca 2+ channels, known to be upregulated in tg/tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg/tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg/tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations.
AB - The Ca 2+ channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Ca v2.1 (P/Q-type) voltage-gated Ca 2+ channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering (tg/tg) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg/tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg/tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca 2+ channel function in either wild-type (WT) or tg/tg mice does not induce the high-power state. In contrast, blocking L-type Ca 2+ channels, known to be upregulated in tg/tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg/tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg/tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations.
KW - Calcium channelopathy
KW - Cerebral cortex
KW - Episodic ataxia type 2
KW - Episodic nervous system dysfunction
KW - Flavoprotein optical imaging
KW - Tottering mouse
UR - http://www.scopus.com/inward/record.url?scp=84929353411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929353411&partnerID=8YFLogxK
U2 - 10.1523/JNEUROSCI.3107-14.2015
DO - 10.1523/JNEUROSCI.3107-14.2015
M3 - Article
C2 - 25855180
AN - SCOPUS:84929353411
SN - 0270-6474
VL - 35
SP - 5664
EP - 5679
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 14
ER -